During the past decade, Kraus Med Partners conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kraus Med Partners" are "HIV Infections" (6 trials), "Herpes Genitalis" (1 trials) and "Herpes Simplex" (1 trials). Many other conditions were trialed in "Kraus Med Partners" in a lesser frequency.

Most popular intervention types in "Kraus Med Partners" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abacavir sulfate" (3 trials), "Adefovir dipivoxil" (1 trials), "Amprenavir" (1 trials), "Efavirenz" (1 trials) and "HIV-1 Immunogen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kraus Med Partners" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Kraus Med Partners". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Kraus Med Partners, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kraus Med Partners, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".